Evaluation of exercise-induced bronchospasm in the adult asthmatic

John Field, Joseph Allegra, Joseph Trautlein, Marilyn Gillin, Robert Zelis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It has been shown that most asthmatics respond to exercise with bronchospasm. This study was undertaken to develop a safe and reliable method for quantifying exercise-induced bronchospasm in the asthmatic adult. Five normal adult volunteers and 12 stable asthmatics were exercised to 80% of their predicted maximal heart rate according to a multistage branching treadmill protocol. Their responses in terms of forced expiratory volume in 1 sec (FEV1) and maximum midexpiratory flow rate (MMEFR) at 5, 15, and 30 min after exercise were assessed, while standing, with a Jones Pulmonar II waterless spirometer. This submaximal stress test was chosen because 80% of predicted maximal heart rate could be obtained by all individuals and allowed the asthmatics to exercise long enough for inducible bronchospasm to occur. Audible wheezing was induced in 100% of the asthmatics and in none of the nonasthmatics. In the normal individuals, FEV1 and MMEFR increased significantly during the postexercise period. When compared to normal subjects, the 12 asthmatic patients demonstrated a significant reduction in FEV1 an MMEFR (ΔFEV1: 5 min, -300; 15 min, -304; 30 min, -208 ml; -18%, -17%, and -15%; ΔMMEFR: 5 min, -15; 15 min, -9; 30 min, -1L/M; -23%, -18%, and -6%) (p < 0.01). The use of a rigidly controlled exercise stress with a cardiovascular endpoint in the measurement of FEV1 and MMEFR in the postexercise period appears to be a useful tool in assessing the presence and severity of exercise-induced bronchospasm in the adult asthmatic.

Original languageEnglish (US)
Pages (from-to)575-580
Number of pages6
JournalThe Journal of Allergy and Clinical Immunology
Volume58
Issue number5
DOIs
StatePublished - Jan 1 1976

Fingerprint

Exercise-Induced Asthma
Forced Expiratory Volume
Exercise
Bronchial Spasm
Heart Rate
Respiratory Sounds
Exercise Test
Healthy Volunteers

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Field, John ; Allegra, Joseph ; Trautlein, Joseph ; Gillin, Marilyn ; Zelis, Robert. / Evaluation of exercise-induced bronchospasm in the adult asthmatic. In: The Journal of Allergy and Clinical Immunology. 1976 ; Vol. 58, No. 5. pp. 575-580.
@article{0b107b534f6d49f7b40a994479d5328f,
title = "Evaluation of exercise-induced bronchospasm in the adult asthmatic",
abstract = "It has been shown that most asthmatics respond to exercise with bronchospasm. This study was undertaken to develop a safe and reliable method for quantifying exercise-induced bronchospasm in the asthmatic adult. Five normal adult volunteers and 12 stable asthmatics were exercised to 80{\%} of their predicted maximal heart rate according to a multistage branching treadmill protocol. Their responses in terms of forced expiratory volume in 1 sec (FEV1) and maximum midexpiratory flow rate (MMEFR) at 5, 15, and 30 min after exercise were assessed, while standing, with a Jones Pulmonar II waterless spirometer. This submaximal stress test was chosen because 80{\%} of predicted maximal heart rate could be obtained by all individuals and allowed the asthmatics to exercise long enough for inducible bronchospasm to occur. Audible wheezing was induced in 100{\%} of the asthmatics and in none of the nonasthmatics. In the normal individuals, FEV1 and MMEFR increased significantly during the postexercise period. When compared to normal subjects, the 12 asthmatic patients demonstrated a significant reduction in FEV1 an MMEFR (ΔFEV1: 5 min, -300; 15 min, -304; 30 min, -208 ml; -18{\%}, -17{\%}, and -15{\%}; ΔMMEFR: 5 min, -15; 15 min, -9; 30 min, -1L/M; -23{\%}, -18{\%}, and -6{\%}) (p < 0.01). The use of a rigidly controlled exercise stress with a cardiovascular endpoint in the measurement of FEV1 and MMEFR in the postexercise period appears to be a useful tool in assessing the presence and severity of exercise-induced bronchospasm in the adult asthmatic.",
author = "John Field and Joseph Allegra and Joseph Trautlein and Marilyn Gillin and Robert Zelis",
year = "1976",
month = "1",
day = "1",
doi = "10.1016/0091-6749(76)90203-7",
language = "English (US)",
volume = "58",
pages = "575--580",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5",

}

Evaluation of exercise-induced bronchospasm in the adult asthmatic. / Field, John; Allegra, Joseph; Trautlein, Joseph; Gillin, Marilyn; Zelis, Robert.

In: The Journal of Allergy and Clinical Immunology, Vol. 58, No. 5, 01.01.1976, p. 575-580.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of exercise-induced bronchospasm in the adult asthmatic

AU - Field, John

AU - Allegra, Joseph

AU - Trautlein, Joseph

AU - Gillin, Marilyn

AU - Zelis, Robert

PY - 1976/1/1

Y1 - 1976/1/1

N2 - It has been shown that most asthmatics respond to exercise with bronchospasm. This study was undertaken to develop a safe and reliable method for quantifying exercise-induced bronchospasm in the asthmatic adult. Five normal adult volunteers and 12 stable asthmatics were exercised to 80% of their predicted maximal heart rate according to a multistage branching treadmill protocol. Their responses in terms of forced expiratory volume in 1 sec (FEV1) and maximum midexpiratory flow rate (MMEFR) at 5, 15, and 30 min after exercise were assessed, while standing, with a Jones Pulmonar II waterless spirometer. This submaximal stress test was chosen because 80% of predicted maximal heart rate could be obtained by all individuals and allowed the asthmatics to exercise long enough for inducible bronchospasm to occur. Audible wheezing was induced in 100% of the asthmatics and in none of the nonasthmatics. In the normal individuals, FEV1 and MMEFR increased significantly during the postexercise period. When compared to normal subjects, the 12 asthmatic patients demonstrated a significant reduction in FEV1 an MMEFR (ΔFEV1: 5 min, -300; 15 min, -304; 30 min, -208 ml; -18%, -17%, and -15%; ΔMMEFR: 5 min, -15; 15 min, -9; 30 min, -1L/M; -23%, -18%, and -6%) (p < 0.01). The use of a rigidly controlled exercise stress with a cardiovascular endpoint in the measurement of FEV1 and MMEFR in the postexercise period appears to be a useful tool in assessing the presence and severity of exercise-induced bronchospasm in the adult asthmatic.

AB - It has been shown that most asthmatics respond to exercise with bronchospasm. This study was undertaken to develop a safe and reliable method for quantifying exercise-induced bronchospasm in the asthmatic adult. Five normal adult volunteers and 12 stable asthmatics were exercised to 80% of their predicted maximal heart rate according to a multistage branching treadmill protocol. Their responses in terms of forced expiratory volume in 1 sec (FEV1) and maximum midexpiratory flow rate (MMEFR) at 5, 15, and 30 min after exercise were assessed, while standing, with a Jones Pulmonar II waterless spirometer. This submaximal stress test was chosen because 80% of predicted maximal heart rate could be obtained by all individuals and allowed the asthmatics to exercise long enough for inducible bronchospasm to occur. Audible wheezing was induced in 100% of the asthmatics and in none of the nonasthmatics. In the normal individuals, FEV1 and MMEFR increased significantly during the postexercise period. When compared to normal subjects, the 12 asthmatic patients demonstrated a significant reduction in FEV1 an MMEFR (ΔFEV1: 5 min, -300; 15 min, -304; 30 min, -208 ml; -18%, -17%, and -15%; ΔMMEFR: 5 min, -15; 15 min, -9; 30 min, -1L/M; -23%, -18%, and -6%) (p < 0.01). The use of a rigidly controlled exercise stress with a cardiovascular endpoint in the measurement of FEV1 and MMEFR in the postexercise period appears to be a useful tool in assessing the presence and severity of exercise-induced bronchospasm in the adult asthmatic.

UR - http://www.scopus.com/inward/record.url?scp=0017091733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017091733&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(76)90203-7

DO - 10.1016/0091-6749(76)90203-7

M3 - Article

C2 - 977864

AN - SCOPUS:0017091733

VL - 58

SP - 575

EP - 580

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -